Tuesday, March 10, 2020 7:59:49 AM
Im with you Dude. I have way more shares than I planned to have, i'm slapping my hand when I go to buy more at these bargain prices...just because of the large % of my total portfolio invested in 1 stock. Though I have full confidence in it...I was just early to the party. Actually not early to the party, just too many negatives happened over the past few months.
What's going to happen if we show over 50million sales for 4th q and an increasing profit? What happens when global expansion and 2.0 revenues are added to that? What happens when Hexo pays up and we see they are not needed as a customer. What happens when the coronavirus fears realize that its just a panic to a bad common cold. Pretty obvious that the government is going to do anything possible from letting a recession happen anytime soon. What happens when Nasdaq approves us? Under 200m market cap...hahaha.
What's going to happen if we show over 50million sales for 4th q and an increasing profit? What happens when global expansion and 2.0 revenues are added to that? What happens when Hexo pays up and we see they are not needed as a customer. What happens when the coronavirus fears realize that its just a panic to a bad common cold. Pretty obvious that the government is going to do anything possible from letting a recession happen anytime soon. What happens when Nasdaq approves us? Under 200m market cap...hahaha.
Recent MEDIF News
- MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- International Medical Sales Surge 43% as GMP Certified Producer Hits Global Growth Phase • AllPennyStocks.com • 03/30/2026 05:47:31 PM
- MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue • GlobeNewswire Inc. • 03/30/2026 11:45:00 AM
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 11:05:48 PM
- MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO • GlobeNewswire Inc. • 01/19/2026 01:00:00 PM
- MediPharm Labs to Enter New Market with Costa Rica Supply Agreement • GlobeNewswire Inc. • 01/13/2026 01:00:00 PM
- Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience • GlobeNewswire Inc. • 12/19/2025 01:45:00 PM
- MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns • GlobeNewswire Inc. • 12/11/2025 01:30:00 AM
- MediPharm Labs Completes First Shipment to France • GlobeNewswire Inc. • 12/04/2025 01:40:00 PM
- MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law • GlobeNewswire Inc. • 11/14/2025 03:00:00 PM
- MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/10/2025 11:00:00 PM
